Search

During the past 15 years, an increasing number of research groups have embraced visible-light-mediated synthetic transformations as a powerful strategy for the construction and functionalization of organic molecules. This trend has followed the advent and development of photocatalysis, which often operates under mild visible-light irradiation. Nowadays, the general perception of UV-light photochemistry is often as an out-of-fashion approach that is difficult to perform and leads to unselective reaction pathways. Here we wish to propose an alternative and more realistic point of view to the scientific community. First, we will provide an overview of the use of UV light in modern photochemistry, highlighting the pivotal role it still plays in the development of new, efficient synthetic methods. We will then show how the high levels of mechanistic understanding reached for UV-light-driven processes have been key in the implementation of the related visible-light-driven transformations.

Herein, we report our study on the design and development of a novel photocarboxylation method. We have used an organic photoredox catalyst (PC, 4CzIPN) and differently substituted dihydropyridines (DHPs) in combination with an organic base (1,5,7-triazabicyclodec-5-ene, TBD) to access a proton-coupled electron transfer (PCET) based manifold. In depth mechanistic investigations merging experimental analysis (NMR, IR, cyclic voltammetry) and density-functional theory (DFT) calculations reveal the key activity of a H-bonding complex between the DHP and the base. The thermodynamic and kinetic benefits of the PCET mechanism allowed the implementation of a redox-neutral fixation process leading to synthetically relevant carboxylic acids (18 examples with isolated yields up to 75%) under very mild reaction conditions. Finally, diverse product manipulations were performed to demonstrate the synthetic versatility of the obtained products.

Mannose-binding lectin (MBL) is a circulating protein that acts as a soluble pattern recognition molecule of the innate immunity. It binds to carbohydrate patterns on the surface of pathogens or of altered self-cells, with activation of the lectin pathway of the complement system. Recent evidence indicates that MBL contributes to the pathophysiology of ischemia-reperfusion injury and other conditions. Thus, MBL inhibitors offer promising therapeutic strategies, since they prevent the interaction of MBL with its target sugar arrays. We developed and characterized a novel assay based on surface plasmon resonance for in vitro screening of these compounds, which may be useful before the more expensive and time-consuming in vivo studies. The assay measures the inhibitor’s ability to interfere with the binding of murine MBL-A or MBL-C, or of human recombinant MBL, to mannose residues immobilized on the sensor chip surface. We have applied the assay to measure the IC50of synthetic glycodendrimers, two of them with neuroprotective properties in animal models of MBL-mediated injuries.